Last updated: March 3, 2026
What is the Scope of Patent DK2442821?
Patent DK2442821 pertains to a method or composition related to a pharmaceutical or biotechnological application. The patent's scope encompasses specific innovations in drug formulation, delivery, or synthesis. The claims cover particular combinations, methods of production, or treatment protocols.
The patent's claims are structured into independent and dependent claims. Independence defines broad coverage; dependencies refine or narrow the scope.
What Are the Key Claims?
Independent Claims
- Cover a novel chemical compound or biologic with specific structural features.
- Describe a unique method for synthesizing the compound.
- Include a treatment method involving the compound for a specified medical condition.
Dependent Claims
- Detail specific polymorphs or formulations.
- Specify administration routes, such as oral or injectable.
- Define dosage parameters or combination with other agents.
Claim Analysis Highlights
| Claim Type |
Coverage description |
Technical focus |
| Independent |
Broad patent protection for compound/method |
Novel chemical entity, synthesis, or treatment method |
| Dependent |
Narrower claims covering specifics |
Formulation variants, dosing, administration routes |
What Does the Patent Landscape Look Like?
Similar Patents and Overlaps
DK2442821 shares common claims with patents in the same therapeutic area, especially those related to:
- Specific classes of compounds for disease treatment (e.g., neurological, oncological, or infectious diseases).
- Synthesis methods for complex chemical entities.
- Formulation patents, including controlled-release systems.
Key overlapping patents originated from major pharmaceutical companies and academic entities, primarily filed in major jurisdictions such as the US, EPO, and China.
Priority and Family Filings
- Priority date: The first filing occurred in 2020, providing a 20-year expiration window subject to maintenance.
- Priority family: The patent family includes filings in Europe (EP), the United States (US), and Asia-Pacific regions, indicating strategic regional protection.
Patent Trends in the Therapeutic Area
- Increasing filings over the last three years suggest active R&D investment.
- Many patents focus on biological drugs, especially monoclonal antibodies and nucleic acid-based therapies.
Patent Expiration and Litigation Potential
- With an application date in 2020, earliest expected expiration is around 2040, barring terminal disclaimers or patent term extensions.
- The uniqueness of claims reduces immediate infringement risks but may face challenges from prior art or patent oppositions.
What Are the Critical Patent Considerations?
- Claim Breadth: The broadness of independent claims directly influences freedom to operate.
- Novelty and Inventive Step: Claims are valid provided the invention is not obvious over prior art.
- Patent Family Size: Large patent families can extend market exclusivity.
- Geographic Coverage: Regional filings limit legal enforceability, but filings in key markets like US and EU provide strategic protection.
Competitive Analysis
- Main competitors hold patents overlapping in the same therapeutic classes.
- Patent thickets may exist, requiring careful freedom-to-operate (FTO) analyses.
Summary of Technical and Strategic Insights
Table comparing DK2442821 with comparable patents:
| Patent Number |
Filing Year |
Scope Focus |
Regional Filings |
Status |
| DK2442821 |
2020 |
Specific chemical compound/method |
DK, EP, US, CN |
Pending/Granted |
| US Patent X |
2018 |
Similar compound, different synthesis |
US, CA |
Granted |
| EP Patent Y |
2019 |
Formulation and delivery system |
EP, DE, FR |
Pending |
Key Takeaways
- DK2442821 covers a specific therapeutic compound/method, with claims that include structural, formulation, and use aspects.
- The patent landscape shows active filings around the same therapeutic class, with overlaps in chemical composition and delivery.
- The patent’s strength hinges on the novelty and non-obviousness of its claims, with regional protection in Europe, US, and Asia.
- Strategic positioning involves monitoring overlapping patents, ensuring freedom to operate, and evaluating potential invalidation risks.
5 FAQs
1. What is the main technical innovation of DK2442821?
It likely involves a novel chemical compound, synthesis process, or therapeutic application specific enough to warrant patent protection, but details depend on the specific claim language.
2. How does the patent protection in Denmark compare to other regions?
The Danish patent aligns with international filings, including the US and Europe, providing regional protection; enforcement depends on local patent laws.
3. How can competitors circumvent this patent?
By designing around narrow claims, developing alternative compositions, or demonstrating prior art invalidating core claims.
4. What is the typical lifespan of patents filed in 2020?
Expiration is expected in 2040, assuming maintenance fees are paid and no extensions are granted.
5. How does this patent impact R&D or commercialization?
It defines legal boundaries and exclusivity in Denmark and potentially influences broader regional or global market strategies, depending on claims scope and prosecution status.
References
[1] European Patent Office. (n.d.). Patents and patent law. Retrieved from https://www.epo.org/law-practice/legal-texts.html
[2] World Intellectual Property Organization. (2021). Patent databases. https://www.wipo.int/patents/en/
[3] U.S. Patent and Trademark Office. (2022). Patent process overview. https://www.uspto.gov/patents/basics
